V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010578 | 330005236 | 0.74 | 82.05 | Adjuvant (A) | 2018-08-08 | 2018-08-10 | Vinblastine weekly | N | N | 330018158 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330010579 | 330005238 | 1.52 | 54 | Curative (C) | 2015-09-08 | 2015-09-15 | Cyclophosphamide + Dex + Rituximab | 02 | null | 330018266 | DA |
| 330010580 | 330005241 | 1.32 | 77.1 | Disease modification (D) | null | 2013-12-13 | Cisplatin + Doxorubicin | 02 | N | 330018316 | CAV |
| 330010581 | 330008859 | 1.8 | 78 | Palliative (P) | 2016-03-02 | 2016-03-11 | FLAG + Idarubicin | 2 | N | 330018401 | FLAG + IDARUBICIN |
| 330010582 | 330005248 | 1.63 | null | Palliative (P) | 2017-09-12 | 2017-09-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | 330018435 | DOCETAXEL |
| 330010583 | 330008864 | 1.83 | 67 | Neo-adjuvant (N) | 2014-05-07 | 2014-05-07 | VAC | N | N | 330018542 | NIVOLUMAB |
| 330010584 | 330005254 | 1.15 | 74.6 | null | 2017-12-16 | 2018-02-18 | Etoposide oral | 02 | N | 330018640 | ETOPOSIDE |
| 330010585 | 330005256 | 1.6 | 47.3 | Palliative (P) | 2014-01-31 | 2014-02-01 | GemCarbo Days 1+8 | 02 | null | 330018645 | GEMCARBO |
| 330010586 | 330005257 | null | 71 | Disease modification (D) | 2014-06-28 | 2014-08-04 | DA 3+8 | null | null | 330018665 | TEMOZOLOMIDE |
| 330010587 | 330005259 | 1.48 | 18.4 | Disease modification (D) | 2017-09-21 | 2017-09-27 | Cisplatin + Doxorubicin | N | N | 330018694 | NIVOLUMAB |
| 330010588 | 330005262 | 1.57 | 26.1 | Palliative (P) | 2013-06-18 | 2013-12-04 | EW EuroEwing 99 : VActI | N | N | 330018705 | EURO-EWING |
| 330010589 | 330005263 | null | 87.6 | Palliative (P) | 2017-06-22 | 2017-06-23 | TEMOZOLOMIDE | 02 | N | 330018720 | NIVOLUMAB |
| 330010590 | 330005263 | 1.55 | 88.4 | Palliative (P) | 2015-12-22 | 2016-01-12 | Liposomal Doxorubicin (Caelyx) | N | N | 330018720 | LIPOSOMAL DOXORUBICIN |
| 330010591 | 330010810 | 1.67 | 68.6 | Neo-adjuvant (N) | null | 2015-06-26 | DA 3+8 | null | null | 330018739 | CISPLATIN + ETOPOSIDE |
| 330010592 | 330005267 | 1.82 | 72.4 | Palliative (P) | 2017-12-07 | 2017-12-07 | Liposomal Doxorubicin (Caelyx) | N | N | 330018777 | LIPOSOMAL DOXORUBICIN |
| 330010593 | 330005275 | 1.6 | 51.45 | null | 2014-11-19 | 2014-11-20 | Etoposide oral | 02 | null | 330018828 | ETOPOSIDE |
| 330010595 | 330008876 | 0 | null | null | 2016-03-29 | 2016-04-01 | Etoposide oral | 02 | N | 330018883 | ETOPOSIDE |
| 330010596 | 330005282 | 0 | 88.2 | Not known (9) | 2014-03-29 | 2014-10-24 | Cisplatin + Doxorubicin | N | N | 330018906 | CISPLATIN + ETOPOSIDE |
| 330010597 | 330005285 | 1.8 | 87.7 | Disease modification (D) | null | 2016-03-18 | CAV | N | N | 330018923 | NIVOLUMAB |
| 330010598 | 330005287 | 1.7 | 65.75 | Curative (C) | 2017-11-14 | 2017-11-18 | EURO-EWING | 02 | N | 330018945 | EURO-EWING |
| 330010599 | 330005290 | null | 94.7 | Adjuvant (A) | 2018-01-13 | 2018-01-28 | GemCarbo Days 1+8 | N | N | 330018956 | GEMCARBO |
| 330010600 | 330005292 | null | 55 | Disease modification (D) | 2016-03-29 | 2016-03-29 | CNS Low Grade Glioma Vinblastine | 2 | N | 330018990 | AZACITIDINE |
| 330010601 | 330010815 | 0 | 66.4 | Not known (9) | 2018-12-11 | 2018-12-11 | Cyclophosphamide + Topotecan | N | N | 330019033 | CAV |
| 330010602 | 330010815 | null | null | Palliative (P) | null | 2016-02-02 | GEMCARBO | null | N | 330019033 | GEMCARBO |
| 330010603 | 330005296 | 0 | null | Not known (9) | 2016-01-27 | 2016-02-03 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330019061 | LIPOSOMAL DOXORUBICIN |
| 330010604 | 330005296 | 1.78 | 70.6 | Disease modification (D) | 2018-02-22 | 2018-02-22 | CAV | 02 | N | 330019061 | AZACITIDINE |
| 330010605 | 330008885 | null | 70.9 | Palliative (P) | 2018-05-09 | 2018-05-09 | DA 3+8 | N | N | 330019079 | VINBLASTINE |
| 330010606 | 330005301 | 0 | 88.2 | Palliative (P) | 2013-09-24 | 2013-09-25 | FLAG + Idarubicin | N | N | 330019100 | FLAG + IDARUBICIN |
| 330010607 | 330008888 | null | 55.2 | Curative (C) | 2015-01-31 | 2015-06-13 | FLAG + Idarubicin | N | N | 330019112 | FLAG + IDARUBICIN |
| 330010608 | 330005306 | 1.67 | 87.1 | Curative (C) | 2016-01-20 | 2016-01-20 | DA 3+8 | 02 | N | 330019124 | CISPLATIN + ETOPOSIDE |
| 330010609 | 330005309 | 1.42 | 70.2 | null | 2016-11-13 | 2016-11-18 | FLAG + Idarubicin | N | N | 330019291 | FLAG + IDARUBICIN |
| 330010610 | 330005310 | 1.81 | 69.4 | Palliative (P) | 2017-09-25 | 2017-10-03 | Azacitidine | N | N | 330019319 | NIVOLUMAB |
| 330010611 | 330005311 | 1.67 | 45.3 | Palliative (P) | 2017-08-20 | 2017-08-21 | Cyclophosphamide + Topotecan | Y | N | 330019327 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010612 | 330005312 | 1.67 | 78.2 | Curative (C) | 2017-02-04 | 2017-02-04 | Liposomal Doxorubicin (Caelyx) | 02 | null | 330019333 | LIPOSOMAL DOXORUBICIN |
| 330010613 | 330010822 | 0 | 8.4 | Palliative (P) | 2016-12-24 | 2017-06-29 | Azacitidine | N | N | 330019347 | CISPLATIN + ETOPOSIDE |
| 330010614 | 330011890 | 1.69 | 81.8 | Palliative (P) | 2015-06-10 | 2015-06-10 | Trabectedin | N | N | 330019369 | TRABECTEDIN |
| 330010615 | 330005315 | null | 63.5 | Palliative (P) | 2014-08-21 | 2014-08-25 | GemCarbo Days 1+8 | Y | N | 330019454 | GEMCARBO |
| 330010616 | 330010824 | 1.69 | null | Palliative (P) | 2017-05-22 | 2017-05-24 | DA 3+8 | N | N | 330019459 | AZACITIDINE |
| 330010618 | 330008897 | 1.75 | 88.8 | Palliative (P) | 2017-01-22 | 2017-01-22 | Methotrexate intrathecal | 02 | N | 330019485 | METHOTREXATE INTRATHECAL |
| 330010619 | 330011893 | 1.77 | 85.7 | null | 2016-07-04 | 2016-07-06 | Azacitidine | 02 | N | 330019500 | CISPLATIN + DOXORUBICIN |
| 330010621 | 330005320 | 0 | 58.4 | Palliative (P) | 2015-10-03 | 2015-10-03 | Docetaxel | 2 | N | 330019510 | DOCETAXEL |
| 330010622 | 330005320 | 1.58 | 48 | Curative (C) | 2013-11-12 | 2014-02-18 | Cyclophosphamide + Dex + Rituximab | N | N | 330019510 | DA |
| 330010623 | 330013260 | 1.6 | null | Curative (C) | 2017-04-24 | 2017-04-30 | EMA/CO | 02 | N | 330019529 | AML17 TRIAL |
| 330010625 | 330005323 | 1.57 | 16 | Palliative (P) | 2016-12-24 | 2016-12-26 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 330019580 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 330010626 | 330008902 | 1.76 | 92 | Not known (9) | 2013-02-27 | 2013-03-28 | IBRUTINIB | 2 | N | 330019584 | UKALL2014 |
| 330010628 | 330005330 | null | 109.2 | Curative (C) | 2015-06-24 | 2015-06-25 | Carboplatin + Pemetrexed | 02 | N | 330019610 | MITOTANE |
| 330010629 | 330005332 | 1.7 | 0 | Curative (C) | 2017-10-13 | 2017-10-14 | NB BEACON Temoz Irin Bev | 02 | N | 330019614 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 330010630 | 330005332 | 1.6 | 62.2 | Disease modification (D) | 2017-04-21 | 2017-04-21 | CISPLATIN + CYCLO + DOXORUBICIN | 2 | null | 330019614 | ALEMTUZUMAB |
| 330010631 | 330005334 | null | null | Palliative (P) | 2015-01-20 | 2015-01-27 | Cetuximab +Cisplatin + FU (Cycle 1) | N | null | 330019624 | MA |
| 330010632 | 330005337 | 1.75 | 70.4 | Curative (C) | 2016-08-31 | 2016-09-02 | R Chlorambucil | N | N | 330019626 | UKALL2014 |